Filing Details

Accession Number:
0001567619-20-011915
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-09 18:01:33
Reporting Period:
2020-06-05
Accepted Time:
2020-06-09 18:01:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70487 National Research Corp NRC Services-Commercial Physical & Biological Research (8731) 470634000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522907 R Kevin Karas C/O National Research Corporation
1245 Q Street
Lincoln NE 68508
Svp Finance, Cfo, Treas & Secy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-05 6,858 $57.28 10,718 No 4 S Direct
Common Stock Disposition 2020-06-05 6,718 $58.62 4,000 No 4 S Direct
Common Stock Acquisiton 2020-06-05 20,088 $14.50 24,088 No 4 M Direct
Common Stock Disposition 2020-06-05 9,704 $57.22 14,384 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2020-06-05 20,088 $0.00 20,088 $14.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-01-07 No 4 M Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually received ranged from $57.00 to $57.80, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $58.00 to $58.93, inclusive.
  3. This option became fully exercisable on January 7, 2018.